Effective date
Medicare changes effective September 25, 2026
5 CMS and MAC policy updates take effect on this date. Every entry links to the government document it came from.
FDA · 5
- FDA Approval: ZUEINO (DICLOFENAC SODIUM) — Type 5 - New Formulation or New Manufacturer
FDA-NDA218379NationalPain Managementsource ↗
- FDA Approval: ATEBRIOZ (ZILURGISERTIB) — Type 1 - New Molecular Entity
FDA-NDA221198NationalHematologysource ↗
- FDA Approval: DEGEVMA (DENOSUMAB-ADET) — Type 5 - New Formulation or New Manufacturer
FDA-BLA761481NationalOncologysource ↗
- FDA Approval: Unknown (Unknown) — Type 2 - New Active Ingredient
FDA-NDA221109NationalNeurologysource ↗
- FDA Approval: JUVMO (TAVAPADON) — Type 1 - New Molecular Entity
FDA-NDA220415NationalNeurologysource ↗